265 related articles for article (PubMed ID: 36761423)
1. m7G-related gene NUDT4 as a novel biomarker promoting cancer cell proliferation in lung adenocarcinoma.
Liu Y; Jiang B; Lin C; Zhu W; Chen D; Sheng Y; Lou Z; Ji Z; Wu C; Wu M
Front Oncol; 2022; 12():1055605. PubMed ID: 36761423
[TBL] [Abstract][Full Text] [Related]
2. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs.
Dai YY; Gao YP; Chen LX; Liu JS; Zeng C; Zhou JD; Wu HL
Front Genet; 2022; 13():930446. PubMed ID: 36110218
[No Abstract] [Full Text] [Related]
3. Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer.
Li T; Chen Z; Wang Z; Lu J; Chen D
Front Immunol; 2023; 14():1260195. PubMed ID: 37868988
[TBL] [Abstract][Full Text] [Related]
4. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
[TBL] [Abstract][Full Text] [Related]
5. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.
Liu P; Dong C; Shi H; Yan Z; Zhang J; Liu J
J Gastrointest Oncol; 2022 Dec; 13(6):3169-3182. PubMed ID: 36636051
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma.
Zhang Y; Gan W; Ru N; Xue Z; Chen W; Chen Z; Wang H; Zheng X
J Bone Oncol; 2023 Jun; 40():100481. PubMed ID: 37139222
[TBL] [Abstract][Full Text] [Related]
7. M7G methylated core genes (METTL1 and WDR4) and associated RNA risk signatures are associated with prognosis and immune escape in HCC.
Li R; Liu X; Deng K; Wang X
BMC Med Genomics; 2023 Aug; 16(1):179. PubMed ID: 37528384
[TBL] [Abstract][Full Text] [Related]
8. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X
Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958
[TBL] [Abstract][Full Text] [Related]
9. Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers.
He CM; Zhang XD; Zhu SX; Zheng JJ; Wang YM; Wang Q; Yin H; Fu YJ; Xue S; Tang J; Zhao XJ
Front Genet; 2022; 13():998147. PubMed ID: 36226166
[No Abstract] [Full Text] [Related]
10. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer.
Zhao B; Fang F; Liao Y; Chen Y; Wang F; Ma Y; Wei C; Zhao J; Ji H; Wang D; Tang D
BMC Bioinformatics; 2023 Mar; 24(1):100. PubMed ID: 36935487
[TBL] [Abstract][Full Text] [Related]
11. N7-Methylguanosine Regulatory Genes Profoundly Affect the Prognosis, Progression, and Antitumor Immune Response of Hepatocellular Carcinoma.
Zhou K; Yang J; Li X; Xiong W; Zhang P; Zhang X
Front Surg; 2022; 9():893977. PubMed ID: 35784919
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma.
Wei W; Liu C; Wang M; Jiang W; Wang C; Zhang S
Front Genet; 2022; 13():906496. PubMed ID: 35938009
[TBL] [Abstract][Full Text] [Related]
13. A Novel 7-Methylguanosine (m7G)-Related Gene Signature for Overall Survival Prediction in Patient with Clear Cell Renal Cell Carcinoma.
Fu Y; Wang J; Hu Z; Gou Y; Li Y; Jiang Q
J Oncol; 2023; 2023():9645038. PubMed ID: 37089261
[TBL] [Abstract][Full Text] [Related]
14. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
Cao J; Liang Y; Gu JJ; Huang Y; Wang B
Front Genet; 2022; 13():991162. PubMed ID: 36353118
[No Abstract] [Full Text] [Related]
15. A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma.
Duan HP; Yan JH; Nie L; Wang Y; Xie H
BMC Pulm Med; 2023 Jan; 23(1):14. PubMed ID: 36635678
[TBL] [Abstract][Full Text] [Related]
16. Identification of N
Ma X; Yang B; Yang Y; Wu G; Ma X; Yu X; Li Y; Wang Y; Guo Q
Front Genet; 2022; 13():946845. PubMed ID: 36105111
[TBL] [Abstract][Full Text] [Related]
17. Analysis and Validation of the Prognosis ability of the M7GRelated miRNAs in Lung Adenocarcinoma.
Qiu X; Chen Y; Zhu X; Gong Z; Yu F; Zhang P; Song Y; Li H
Asian Pac J Cancer Prev; 2023 Apr; 24(4):1275-1287. PubMed ID: 37116150
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns and prognostic value of key regulators associated with m7G RNA modification based on all gene expression in colon adenocarcinoma.
Zhu Y; Zhao Z; Thandar M; Cheng J; Chi P; Huang S
BMC Gastroenterol; 2023 Jan; 23(1):22. PubMed ID: 36681801
[TBL] [Abstract][Full Text] [Related]
19. Construction and Validation of a m7G-Related Gene-Based Prognostic Model for Gastric Cancer.
Li XY; Wang SL; Chen DH; Liu H; You JX; Su LX; Yang XT
Front Oncol; 2022; 12():861412. PubMed ID: 35847903
[TBL] [Abstract][Full Text] [Related]
20. Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma.
Li Y; Zhao K; Wu R; Wang J; Wang Q; Xiong Q; Xie F; Lei H; Feng P
J Gastrointest Oncol; 2023 Jun; 14(3):1392-1411. PubMed ID: 37435203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
